Mark Garside

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Rustam Al‐Shahi Salman, M. J. S. Dennis, PAG Sandercock et al. · The Lancet · 2019 · 195 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

Philip M. Bath, Lisa J Woodhouse, Jason P. Appleton et al. · The Lancet · 2017 · 180 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial

Melinda B Roaldsen, Agnethe Eltoft, Tom Wilsgaard et al. · The Lancet Neurology · 2022 · 100 citations · Full text

Medicine, Neurology, Radiology +12

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Rustam Al‐Shahi Salman, David Minks, Dipayan Mitra et al. · The Lancet Neurology · 2019 · 89 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage

Rustam Al‐Shahi Salman, Martin Dennis, Peter Sandercock et al. · JAMA Neurology · 2021 · 48 citations · Full text

Medicine, Neurology, Pharmacotherapy +17